Research Library

Curated Studies & Clinical Data

A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.

265Curated Studies
19Compounds Covered
2Clinical Trials
170Journals Referenced
PRECLINICAL / IN VIVO

Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury

Yu X, Yang T, Bei Z, et al.

Bioactive materials, 2026;63:778-794

GHK-Cu
PRECLINICAL / IN VIVO

Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model

Hu J, Zhang C, Wang F

European journal of pharmacology, 2026;1023:178880

GHK-Cu
PRECLINICAL / IN VIVO

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

Mendias CL, Awan TM

Sports medicine (Auckland, N.Z.), 2026

BPC-157 CJC-1295 GHK-Cu ipamorelin sermorelin TB-500 tesamorelin thymosin
PRECLINICAL / IN VIVO

Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics

Sikiric P, Barisic I, Udovicic M, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(3)

PRECLINICAL / IN VIVO

Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review

Matek D, Matek I, Japjec M, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(2)

PRECLINICAL / IN VIVO

Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications

Lachowicz JI, Congiu T, Salis A, et al.

International journal of molecular sciences, 2026;27(4)

thymosin
PRECLINICAL / IN VIVO

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias

Sikiric P, Barisic I, Udovicic M, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(2)

PRECLINICAL / IN VIVO

Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats

Smoday IM, Vukovic V, Oroz K, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(1)

PRECLINICAL / IN VIVO

Decidualization-empowered ECM hydrogel integrating sustained Tβ4 release drives endometrial regeneration in intrauterine adhesions

Liang Y, Yu Z, Du S, et al.

Nature communications, 2026;17(1)

thymosin
PRECLINICAL / IN VIVO

Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats

Madzarac G, Becejac T, Penovic T, et al.

Pharmaceuticals (Basel, Switzerland), 2026;19(1)

PRECLINICAL / IN VIVO

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

Mayfield CK, Bolia IK, Feingold CL, et al.

The American journal of sports medicine, 2026;54(1):223-229

BPC-157 CJC-1295 GHK-Cu ipamorelin TB-500 tesamorelin
PRECLINICAL / IN VIVO

Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 × FAD mice: A potential therapy for memory improvement in Alzheimer’s disease

Ou H, Chen R, Zhou L, et al.

International immunopharmacology, 2025;170:116097

thymosin
PRECLINICAL / IN VIVO

Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy

Masnec S, Kokot A, Kralj T, et al.

Pharmaceuticals (Basel, Switzerland), 2025;18(12)

PRECLINICAL / IN VIVO

The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons

Kolbaev SN, Sharonova IN, Skrebitsky VG

Bulletin of experimental biology and medicine, 2025;179(4):416-420

semax
PRECLINICAL / IN VIVO

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry

Uçaktürk E, Nemutlu E

Journal of pharmaceutical and biomedical analysis, 2025;268:117207

CJC-1295 sermorelin tesamorelin
PRECLINICAL / IN VIVO

BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185

Sikiric P, Seiwerth S, Skrtic A, et al.

Pharmaceuticals (Basel, Switzerland), 2025;18(10)

PRECLINICAL / IN VIVO

Effect of ACTH4-10Pro8-Gly9-Pro10 on anti-inflammatory cytokine (IL-4, IL-10, IL-13) expression in acute spinal cord injury models (male Sprague Dawley rats)

Asadullah A, Bajamal AH, Parenrengi MA, et al.

F1000Research, 2025;12:194

semax
PRECLINICAL / IN VIVO

Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution

Jin Z, Li H, Li J, et al.

Cellular signalling, 2025;136:112111

thymosin
PRECLINICAL / IN VIVO

Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids

Zeng PM, Sun XY, Li Y, et al.

Stem cell reports, 2025;20(9):102601

thymosin
PRECLINICAL / IN VIVO

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing

McGuire FP, Martinez R, Lenz A, et al.

Current reviews in musculoskeletal medicine, 2025;18(12):611-619

BPC-157

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.